Anthem Biosciences Limited
Kotak Mutual Fund bought 13,42,643 shares of Anthem Biosciences Limited for ₹100.00 Cr at ₹744.80 apiece in a block deal.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.